Commitment to Action

Accelerating Malaria Vaccine Research

Commitment by

Bill & Melinda Gates Foundation

In 2008, the Bill and Melinda Gates Foundation committed to provide $168 million in grants to the PATH Malaria Vaccine Initiative (MVI). MVI's mission is to accelerate the development of promising malaria vaccines, and to ensure that these vaccines are available and accessible in developing countries. Through this commitment, MVI will be able to significantly expand its pipeline of candidate vaccines, and accelerate the development of promising malaria vaccines.

At last reporting in 2011, the RTS,S Malaria vaccine is in its phase-3 trial stage, and may be available for use as early as 2015.

Share

Tabs

Overview
Summary

Commitment

Accelerating Malaria Vaccine Research

Launched

2008

Est. Duration

11-15 years

Region

Africa

Countries

Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique, Tanzania

Commitment by

Bill & Melinda Gates Foundation

Partner(s)

PATH